Carboxypeptidase M is a positive allosteric modulator of the kinin B1 receptor

Journal of Biological Chemistry

Volumn 288, Issue 46, 2013, Pages 33226-33240

  Zhang, Xianming ^a   Tan, Fulong ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOSTERIC MODULATION; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONFORMATIONAL CHANGE; EXTRACELLULAR DOMAINS; EXTRACELLULAR LOOP 2; G PROTEIN COUPLED RECEPTORS; POSITIVE ALLOSTERIC MODULATOR; PROTEIN-PROTEIN INTERACTIONS;

ENZYME ACTIVITY; PROTEINS; SIGNALING;

CELL SIGNALING;

BRADYKININ B1 RECEPTOR; CALCIUM ION; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; DESARGININE KALLIDIN 10; EPITOPE; KALLIDIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITIDE; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CARBOXY TERMINAL SEQUENCE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; BRADYKININ; CARBOXYPEPTIDASE; G PROTEIN-COUPLED RECEPTORS (GPCR); GLYCOSYL PHOSPHATIDYLINOSITOL ANCHORS; KALLIDIN; PEPTIDASES; PEPTIDE HORMONES;

ALLOSTERIC REGULATION; GPI-LINKED PROTEINS; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; METALLOENDOPEPTIDASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, BRADYKININ B1;

EID: 84887829502     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.520791     Document Type: Article

References (74)

1. Zhang, X., and Skidgel, R. (2013) in Handbook of Proteolytic Enzyme (Rawlings, N. D., and Salvesen, G. S., eds) pp. 1357-1366, 3rd Ed., Academic Press, Oxford
2. Gomis-Rüth, F. X. (2008) Structure and mechanism of metallocarboxypeptidases. Crit. Rev. Biochem. Mol. Biol. 43, 319-345
3. Li, J., Rehli, M., Timblin, B., Tan, F., Krause, S. W., and Skidgel, R. A. (2002) Structure of the human carboxypeptidase M gene. Identification of a proximal GC-rich promoter and a unique distal promoter that consists of repetitive elements. Gene 284, 189-202
4. Tan, F., Chan, S. J., Steiner, D. F., Schilling, J. W., and Skidgel, R. A. (1989) Molecular cloning and sequencing of the cDNA for human membranebound carboxypeptidase M. Comparison with carboxypeptidases A, B, H, and N. J. Biol. Chem. 264, 13165-13170
5. Reverter, D., Maskos, K., Tan, F., Skidgel, R. A., and Bode, W. (2004) Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J. Mol. Biol. 338, 257-269
6. Skidgel, R. A., and Erdös, E. G. (1998) Cellular carboxypeptidases. Immunol. Rev. 161, 129-141
7. Reznik, S. E., and Fricker, L. D. (2001) Carboxypeptidases from A to Z. Implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 58, 1790-1804
8. Deddish, P. A., Skidgel, R. A., Kriho, V. B., Li, X. Y., Becker, R. P., and Erdös, E. G. (1990) Carboxypeptidase M in Madin-Darby canine kidney cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor. J. Biol. Chem. 265, 15083-15089
9. Li, X. Y., and Skidgel, R. A. (1999) Release of glycosylphosphatidylinositolanchored carboxypeptidaseMby phosphatidylinositol- specific phospholipase C up-regulates enzyme synthesis. Biochem. Biophys. Res. Commun. 258, 204-210
10. Deiteren, K., Hendriks, D., Scharpé, S., and Lambeir, A. M. (2009) Carboxypeptidase M. Multiple alliances and unknown partners. Clin. Chim. Acta 399, 24-39
11. Skidgel, R. A. (1988) Basic carboxypeptidases. Regulators of peptide hormone activity. Trends Pharmacol. Sci. 9, 299-304
12. Skidgel, R. A., Davis, R. M., and Tan, F. (1989) Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J. Biol. Chem. 264, 2236-2241
13. Kuhr, F., Lowry, J., Zhang, Y., Brovkovych, V., and Skidgel, R. A. (2010) Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides 44, 145-154
14. Leeb-Lundberg, L. M., Marceau, F., Müller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family. From molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77
15. Talbot, S., Chahmi, E., Dias, J. P., and Couture, R. (2010) Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. J. Neuroinflammation 7, 36
16. Su, J. B. (2006) Kinins and cardiovascular diseases. Curr. Pharm. Des. 12, 3423-3435
17. Duka, I., Duka, A., Kintsurashvili, E., Johns, C., Gavras, I., and Gavras, H. (2003) Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin. Hypertension 42, 1021-1025
18. Hillmeister, P., Gatzke, N., Dülsner, A., Bader, M., Schadock, I., Hoefer, I., Hamann, I., Infante-Duarte, C., Jung, G., Troidl, K., Urban, D., Stawowy, P., Frentsch, M., Li, M., Nagorka, S., Wang, H., Shi, Y., le Noble, F., and Buschmann, I. (2011) Arteriogenesis is modulated by bradykinin receptor signaling. Circ. Res. 109, 524-533
19. Merino, V. F., Todiras, M., Campos, L. A., Saul, V., Popova, E., Baltatu, O. C., Pesquero, J. B., and Bader, M. (2008) Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors. J. Mol. Med. 86, 791-798
20. Pesquero, J. B., Araujo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, J. A., Jr., Walther, T., Oliveira, S. M., Pesquero, J. L., Paiva, A. C., Calixto, J. B., Lewin, G. R., and Bader, M. (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 8140-8145
21. Cayla, C., Todiras, M., Iliescu, R., Saul, V. V., Gross, V., Pilz, B., Chai, G., Merino, V. F., Pesquero, J. B., Baltatu, O. C., and Bader, M. (2007) Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J. 21, 1689-1698
22. Alhenc-Gelas, F., Bouby, N., Richer, C., Potier, L., Roussel, R., and Marre, M. (2011) Kinins as therapeutic agents in cardiovascular and renal diseases. Curr. Pharm. Des. 17, 2654-2662
23. Potier, L., Waeckel, L., Vincent, M. P., Chollet, C., Gobeil, F., Jr., Marre, M., Bruneval, P., Richer, C., Roussel, R., Alhenc-Gelas, F., and Bouby, N. (2013) Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes. J. Pharmacol. Exp. Ther. 346, 23-30
24. Erdös, E. G., Tan, F., and Skidgel, R. A. (2010) Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 55, 214-220
25. Tschöpe, C., Spillmann, F., Altmann, C., Koch, M., Westermann, D., Dhayat, N., Dhayat, S., Bascands, J. L., Gera, L., Hoffmann, S., Schultheiss, H. P., and Walther, T. (2004) The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc. Res. 61, 559-569
26. Vijayaraghavan, K., and Deedwania, P. (2011) Renin-angiotensin- aldosterone blockade for cardiovascular disease prevention. Cardiol. Clin. 29, 137-156
27. Skidgel, R. A. (1996) in Zinc Metalloproteases in Health and Disease (Hooper, N. M., ed) pp. 241-283, Taylor & Francis Ltd., London 28.
28. Skidgel, R. A., and Erdös, E. G. (1998) in Pro-inflammatory and Antiinflammatory Peptides.(Said, S. I., ed)pp 459-476, Marcel Dekker, Inc., New York
29. Zhang, X., Tan, F., Brovkovych, V., Zhang, Y., Lowry, J. L., and Skidgel, R. A. (2013) CarboxypeptidaseMaugments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output. Biol. Chem. 394, 335-345
30. McGwire, G. B., and Skidgel, R. A. (1995) Extracellular conversion of epidermal growth factor (EGF) to des-Arg53-EGF by carboxypeptidase M. J. Biol. Chem. 270, 17154-17158
31. Hadkar, V., Sangsree, S., Vogel, S. M., Brovkovych, V., and Skidgel, R. A. (2004) Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L35-L45
32. Sangsree, S., Brovkovych, V., Minshall, R. D., and Skidgel, R. A. (2003) Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am. J. Physiol. Heart Circ. Physiol. 284, H1959-H1968
33. Schremmer-Danninger, E., Offner, A., Siebeck, M., and Roscher, A. A. (1998) B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem. Biophys. Res. Commun. 243, 246-252
34. Zhang, X., Tan, F., Zhang, Y., and Skidgel, R. A. (2008) Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient B1 signaling from B2 agonists. J. Biol. Chem. 283, 7994-8004
35. Zhang, X., Tan, F., Brovkovych, V., Zhang, Y., and Skidgel, R. A. (2011) Cross-talk between carboxypeptidaseMand the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling. J. Biol. Chem. 286, 18547-18561
36. Wang, C. I., and Lewis, R. J. (2013) Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem. Pharmacol. 85, 153-162
37. Kenakin, T. P. (2009) 7TM receptor allostery. Putting numbers to shapeshifting proteins. Trends Pharmacol. Sci. 30, 460-469
38. Tan, F., Deddish, P. A., and Skidgel, R. A. (1995) Human carboxypeptidase M. Methods Enzymol. 248, 663-675
39. Tan, F., Balsitis, S., Black, J. K., Blöchl, A., Mao, J. F., Becker, R. P., Schacht, D., and Skidgel, R. A. (2003) Effect of mutation of two critical glutamic acid residues on the activity and stability of human carboxypeptidase M and characterization of its signal for glycosylphosphatidylinositol anchoring. Biochem. J. 370, 567-578
40. Marcic, B., Deddish, P. A., Skidgel, R. A., Erdös, E. G., Minshall, R. D., and Tan, F. (2000) Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors. J. Biol. Chem. 275, 16110-16118
41. Kalatskaya, I., Schüssler, S., Blaukat, A., Müller-Esterl, W., Jochum, M., Proud, D., and Faussner, A. (2004) Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor. J. Biol. Chem. 279, 31268-31276
42. Pfleger, K. D., Seeber, R. M., and Eidne, K. A. (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of proteinprotein interactions. Nat. Protoc. 1, 337-345
43. Deddish, P. A., Skidgel, R. A., and Erdös, E. G. (1989) Enhanced Co2 activation and inhibitor binding of carboxypeptidase M at low pH. Similarity to carboxypeptidase H (enkephalin convertase). Biochem. J. 261, 289-291
44. Leeb-Lundberg, L. M., Kang, D. S., Lamb, M. E., and Fathy, D. B. (2001) The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains. J. Biol. Chem. 276, 8785-8792
45. Tan, F., Rehli, M., Krause, S. W., and Skidgel, R. A. (1997) Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem. J. 327, 81-87
46. Aloy, P., Companys, V., Vendrell, J., Aviles, F. X., Fricker, L. D., Coll, M., and Gomis-Rüth, F. X. (2001) The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases. J. Biol. Chem. 276, 16177-16184
47. Eng, F. J., Novikova, E. G., Kuroki, K., Ganem, D., and Fricker, L. D. (1998) gp180, a protein that binds duck hepatitis B virus particles, has metallocarboxypeptidase D-like enzymatic activity. J. Biol. Chem. 273, 8382-8388
48. Keil, C., Maskos, K., Than, M., Hoopes, J. T., Huber, R., Tan, F., Deddish, P. A., Erdös, E. G., Skidgel, R. A., and Bode, W. (2007) Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J. Mol. Biol. 366, 504-516
49. May, L. T., Leach, K., Sexton, P. M., and Christopoulos, A. (2007) Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 47, 1-51
50. Avlani, V. A., Gregory, K. J., Morton, C. J., Parker, M. W., Sexton, P. M., and Christopoulos, A. (2007) Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands. J. Biol. Chem. 282, 25677-25686
51. Unal, H., and Karnik, S. S. (2012) Domain coupling in GPCRs. The engine for induced conformational changes. Trends Pharmacol. Sci. 33, 79-88
52. Skidgel, R. A., Johnson, A. R., and Erdös, E. G. (1984) Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem. Pharmacol. 33, 3471-3478
53. Burford, N. T., Watson, J., Bertekap, R., and Alt, A. (2011) Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Biochem. Pharmacol. 81, 691-702
54. Canals, M., Sexton, P. M., and Christopoulos, A. (2011) Allostery in GPCRs. "MWC" revisited. Trends Biochem. Sci. 36, 663-672
55. Hoffmann, C., Gaietta, G., Bünemann, M., Adams, S. R., Oberdorff-Maass, S., Behr, B., Vilardaga, J. P., Tsien, R. Y., Ellisman, M. H., and Lohse, M. J. (2005) A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat. Methods 2, 171-176
56. Nakanishi, J., Takarada, T., Yunoki, S., Kikuchi, Y., and Maeda, M. (2006) FRET-based monitoring of conformational change of the β2 adrenergic receptor in living cells. Biochem. Biophys. Res. Commun. 343, 1191-1196
57. Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., and Babu, M. M. (2013) Molecular signatures of G-protein-coupled receptors. Nature 494, 185-194
58. Jacoby, E., Bouhelal, R., Gerspacher, M., and Seuwen, K. (2006) The 7 TM G-protein-coupled receptor target family. Chem. Med. Chem. 1, 761-782
59. Smith, N. J., and Milligan, G. (2010) Allostery at G protein-coupled receptor homo- and heteromers. Uncharted pharmacological landscapes. Pharmacol. Rev. 62, 701-725
60. Conn, P. J., Christopoulos, A., and Lindsley, C. W. (2009) Allosteric modulators of GPCRs. A novel approach for the treatment of CNS disorders. Nat. Rev. Drug Discov. 8, 41-54
61. Ritter, S. L., and Hall, R. A. (2009) Fine-tuning of GPCR activity by receptor- interacting proteins. Nat. Rev. Mol. Cell Biol. 10, 819-830
62. Bokoch, M. P., Zou, Y., Rasmussen, S. G., Liu, C. W., Nygaard, R., Rosenbaum, D. M., Fung, J. J., Choi, H. J., Thian, F. S., Kobilka, T. S., Puglisi, J. D., Weis, W. I., Pardo, L., Prosser, R. S., Mueller, L., and Kobilka, B. K. (2010) Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463, 108-112
63. Wheatley, M., Wootten, D., Conner, M. T., Simms, J., Kendrick, R., Logan, R. T., Poyner, D. R., and Barwell, J. (2012) Lifting the lid on GPCRs. The role of extracellular loops. Br. J. Pharmacol. 165, 1688-1703
64. Unal, H., Jagannathan, R., and Karnik, S. S. (2012) Mechanism of GPCRdirected autoantibodies in diseases. Adv. Exp. Med. Biol. 749, 187-199
65. Klco, J. M., Wiegand, C. B., Narzinski, K., and Baranski, T. J. (2005) Essential role for the second extracellular loop in C5a receptor activation. Nat. Struct. Mol. Biol. 12, 320-326
66. Westermann, D., Walther, T., Savvatis, K., Escher, F., Sobirey, M., Riad, A., Bader, M., Schultheiss, H. P., and Tschöpe, C. (2009) Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes 58, 1373-1381
67. Pesquero, J. B., and Bader, M. (2006) Genetically altered animal models in the kallikrein-kinin system. Biol. Chem. 387, 119-126
68. Kakoki, M., McGarrah, R. W., Kim, H. S., and Smithies, O. (2007) Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/ reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 104, 7576-7581
69. Moniwa, N., Agata, J., Hagiwara, M., Ura, N., and Shimamoto, K. (2006) The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP). Biol. Chem. 387, 203-209
70. Hagiwara, M., Murakami, H., Ura, N., Agata, J., Yoshida, H., Higashiura, K., and Shimamoto, K. (2004) Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 27, 399-408
71. Emanueli, C., Bonaria Salis, M., Stacca, T., Pintus, G., Kirchmair, R., Isner, J. M., Pinna, A., Gaspa, L., Regoli, D., Cayla, C., Pesquero, J. B., Bader, M., and Madeddu, P. (2002) Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation 105, 360-366
72. Duka, A., Kintsurashvili, E., Duka, I., Ona, D., Hopkins, T. A., Bader, M., Gavras, I., and Gavras, H. (2008) Angiotensin-converting enzyme inhibition after experimental myocardial infarct. Role of the kinin B1 and B2 receptors. Hypertension 51, 1352-1357
73. Xu, J., Carretero, O. A., Shesely, E. G., Rhaleb, N. E., Yang, J. J., Bader, M., and Yang, X. P. (2009) The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice. Exp. Physiol. 94, 322-329
74. Ignjatovic, T., Tan, F., Brovkovych, V., Skidgel, R. A., and Erdös, E. G. (2002) Novel mode of action of angiotensin I converting enzyme inhibitors. Direct activation of bradykinin B1 receptor. J. Biol. Chem. 277, 16847-16852